Waystar Holding Corp. 10-Q Summary: Q1 2025
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. Waystar Holding Corp. (NASDAQ: WAY) provides mission-critical cloud technology to healthcare organizations, streamlining payment workflows for providers, patients, and payers. The company operates as a single reportable segment and serves over 30,000 clients, including 16 of the top 20 U.S. News Best Hospitals. Waystar is classified as an emerging growth company and a non-accelerated filer.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenue | $256.4 million | $224.8 million |
| Net Income | $29.3 million | ($15.9 million) loss |
| Operating Income | $65.2 million | $35.2 million |
| Adjusted EBITDA | $107.7 million | $92.8 million |
| Operating Cash Flow | $64.2 million | $10.7 million |
| Cash and Equivalents | $224.0 million | $57.3 million |
| Total Debt (Outstanding) | $1.24 billion | $1.24 billion |
| Net Revenue Retention Rate (LTM) | 113.5% | 108.8% |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $29.3 million in Q1 2025, a significant improvement from a net loss of $15.9 million in Q1 2024. This was driven by a 14.1% revenue increase and a 67.2% reduction in interest expense.
- Revenue Growth: Revenue grew by $31.6 million year-over-year. Approximately $10 million of this increase is attributed to accelerated client adoption following a cybersecurity incident at a competitor in February 2024.
- Interest Expense Reduction: Total interest expense dropped from $57.2 million to $18.9 million. This decrease is primarily due to the repayment of $1.0 billion in debt using IPO proceeds in 2024 and the absence of a loss on debt extinguishment recorded in the prior year.
- Amortization Decline: Depreciation and amortization expenses decreased by 24.4% ($10.8 million) as several intangible assets became fully amortized by the end of 2024.
- Liquidity Position: Cash and cash equivalents increased significantly to $224.0 million from $57.3 million, bolstered by strong operating cash flows and the purchase of $24.4 million in investment securities.
Guidance, Outlook, and Risks
Management Commentary: Management highlights strong recurring revenue visibility, with over 99% of revenue derived from subscription and volume-based models. The company continues to leverage AI and network effects to improve platform performance. A secondary offering of 23 million shares by Institutional Investors occurred in February 2025; the company did not receive proceeds from this transaction.
Subsequent Events: On April 1 and April 9, 2025, the company entered into new interest rate swaps to hedge against rising rates on its First Lien Credit Facility, fixing rates on $355 million of debt.
Risks and Contingencies:
- Regulatory Environment: The company operates in a heavily regulated healthcare industry subject to evolving laws regarding data privacy, cybersecurity, and payment processing.
- Competition: The market is highly competitive; however, recent competitor vulnerabilities have accelerated Waystar's win rates.
- Interest Rate Risk: A significant portion of debt is variable-rate (SOFR-based), though hedging instruments are in place to mitigate exposure.
- Concentration: While the client base is diversified, the company relies on third-party vendors and infrastructure providers.
Investor Verification Checklist
- Verify the sustainability of the $10 million revenue uplift attributed to the competitor's cybersecurity incident.
- Review the terms of the new interest rate swaps entered into in April 2025 to assess future interest cost stability.
- Monitor the amortization schedule of intangible assets to confirm the trajectory of future D&A expenses.
- Assess the impact of the Secondary Offering on potential future dilution, noting the company received no proceeds.
- Confirm compliance with debt covenants, specifically collection thresholds related to the Receivables Facility.